The genetic testing agency 23andMe has filed for chapter, one other twist within the story of an organization that promised a pioneering strategy to precision well being. Now customers are scrambling to delete their private knowledge, with the long run possession of the agency unsure. To know the highs and lows of 23andMe’s journey, Madeleine Finlay hears from the Guardian US tech reporter and editor Johana Bhuiyan, and from Timothy Caulfield, a professor of regulation on the College of Alberta, who has a particular curiosity in well being and biotechnology
Supply hyperlink
